NME1 and ovarian carcinoma: Almost half of the overlapping genes (11/27, 41%) have asignificant number (>5 publications) of prior reports in the literatureimplicating a role in ovarian cancer, including NME1, whereas13/27, 48% represent novel candidates (Table 5).